Published January 1, 2014
| Version v1
Journal article
Open
Long-Term Follow-Up of Children With Congenital Hyperinsulinism on Octreotide Therapy
Creators
- 1. Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England
Description
Context: Octreotide, a somatostatin analog, is commonly used in diazoxide unresponsive congenital hyperinsulinism (CHI) patients as a second-line therapy.
Files
bib-14a98927-83cc-446d-b748-689d784c46ab.txt
Files
(249 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:811b964c4591961d629fc94224552a3a
|
249 Bytes | Preview Download |